The vast majority of people who have a substance use disorder (SUD) never seek treatment. At most, 10% of adults with a drug ...

Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.

Clinical neuroscientist Joe Schacht offered an overview of the research on weight-loss drugs for alcoholism, other potential ...